相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Scott R. Goldsmith et al.
BLOOD (2021)
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation
Morgan Hakki et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults
Surabhi B. Vora et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
Kitsada Wudhikarn et al.
BLOOD CANCER JOURNAL (2020)
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
Sung-Yeon Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Guy El Helou et al.
INFECTION AND DRUG RESISTANCE (2019)
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma
Jia Wei et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation
Jose Paulo Martins et al.
SCIENCE (2019)
Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
F. Marchesi et al.
HEMATOLOGICAL ONCOLOGY (2018)
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
Jae H. Park et al.
CLINICAL INFECTIOUS DISEASES (2018)
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Kaiwen Chen et al.
BLOOD ADVANCES (2018)
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
Joshua A. Hill et al.
BLOOD (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population
T. -d. Li et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Review of cytomegalovirus coinfection in HIV-infected individuals in Africa
Helene Ladefoged Gronborg et al.
REVIEWS IN MEDICAL VIROLOGY (2017)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Frederick L. Locke et al.
MOLECULAR THERAPY (2017)
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer et al.
BLOOD (2016)
Antiviral prophylaxis in patients with solid tumours and haematological malignancies-update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Michael Sandherr et al.
ANNALS OF HEMATOLOGY (2015)
Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
Chien-Li Holmes-Liew et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Cytomegalovirus pneumonia in patients with lymphoma
RF Chemaly et al.
CANCER (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients
FM Mattes et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products
KG Nichols et al.
BLOOD (2003)
Cytomegalovirus pneumonia in adults with leukemia: An emerging problem
Q Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2001)
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
P Ljungman et al.
BLOOD (2001)
分享论文
